Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

I S Nijhof, L E Franssen, MD Levin, GMJ Bos, A. Broijl, Saskia Klein, H R Koene, AC Bloem, A Beeker, LM Faber, E van der Spek, PF Ypma, R Raymakers, DJ van Spronsen, PE Westerweel, R Oostvogels, J van Velzen, B van Kessel, T Mutis, Pieter SonneveldS Zweegman, HM Lokhorst, NWCJ v.d. Donk

Research output: Contribution to journalArticleAcademicpeer-review

47 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2297-2306
Number of pages10
Issue number19
Publication statusPublished - 2016

Cite this